ENDPOINTS

#ASCO25: Merus’ Phase 2 overall survival data reach ‘home run’ scenario — analyst

Merus completed its rollout of Phase 2 head and neck cancer data on Thursday, touting overall survival results that at least one analyst said amount to a best-case outcome. In the trial, patients got Merus' ...

May 22, 2025 - 22:34
 0
#ASCO25: Merus’ Phase 2 overall survival data reach ‘home run’ scenario — analyst
Merus completed its rollout of Phase 2 head and neck cancer data on Thursday, touting overall survival results that at least one analyst said amount to a best-case outcome. In the trial, patients got Merus' ...
Read More

Tags:

Previous Article

A new nanometer-scale measurement tool exploits the quantum properties of light ...

Next Article

WellTheory raises $5M for AI-enabled autoimmune care platform

Related Posts

David Liu, Sam Sternberg unveil new way to insert big genes in human cells

David Liu, Sam Sternberg unveil new way to insert big g...

May 19, 2025  0

Bristol Myers CEO says America’s biopharma pole position is not guaranteed

Bristol Myers CEO says America’s biopharma pole positio...

May 15, 2025  0

FDA vaccine advisors update Covid strain guidance following new framework

FDA vaccine advisors update Covid strain guidance follo...

May 22, 2025  0